Search Clinical Trials Search
Clinical Trials
× ...
Sort & Filter
Sort by
Specialty

Disease or Condition

Age Group


Drug/Medication


13 results found


Lung

Biomarker-Driven Therapies and Immunotherapies in Non-Small Cell Lung Cancer

This study focuses on patients with non-small cell lung cancer. The purpose is to study tumor tissue to determine whether a targeted or immunotherapy treatment will have an effect on specific genes and proteins in ...


Lung

Trastuzumab Deruxtecan in Non-Small Cell Lung Cancer

This study focuses on individuals who have unresectable, locally advanced or metastatic lung cancer with a mutation on the human epidermal growth factor receptor 2 (HER2). HER2 is a protein found on the surface of ...


Lung Cancer, Non-small cell

IOV-4001 in Melanoma or Non-Small-Cell Lung Cancer

The purpose of this study is to determine whether an investigational drug called IOV-4001 is safe and beneficial in the treatment of patients with unresectable or metastatic melanoma or advanced non-small cell lung cancer (NSCLC). ...


Breast cancer, Colon cancer, Lung Cancer, Melanoma, Rectal Cancer, Solid ...

GV20-0251 in Advanced and/or Refractory Solid Tumor Malignancies

The purpose of the study is to determine whether an experimental drug called GV20-0251 is safe and tolerable in patients with solid tumors that have not been successfully treated with standard therapies. GV20-0251 is a ...


Lung

Non-Small Cell Lung Cancer: Lung-MAP Sub-Study

The purpose of this study is to determine whether a combination of drugs (capmatinib, osimertinib, and ramucirumab) is beneficial compared to another combination (capmatinib and osimertinib) for treating non-small cell lung cancer tumors that have ...